2018
DOI: 10.1093/europace/euy176
|View full text |Cite
|
Sign up to set email alerts
|

Detection of atrial fibrillation with a smartphone camera: first prospective, international, two-centre, clinical validation study (DETECT AF PRO)

Abstract: ClinicalTrials.gov, number NCT02949180, https://clinicaltrials.gov/ct2/show/NCT02949180.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
87
1
8

Year Published

2019
2019
2021
2021

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 129 publications
(100 citation statements)
references
References 20 publications
4
87
1
8
Order By: Relevance
“…However, in order to be accepted by the medical community, the potential value relevant to the use of these technologies needs to be proved. While the use of smartphone cameras using photoplethysmography for early detection of atrial fibrillation, based on the analysis of beat-by-beat duration variability series, has initially proved its value in a prospective two-center, international clinical validation study [40], the validation of using smartphone accelerometers is still limited and again focusing on beat-by-beat duration variability only [16], [17], [41], [42].…”
Section: Discussionmentioning
confidence: 99%
“…However, in order to be accepted by the medical community, the potential value relevant to the use of these technologies needs to be proved. While the use of smartphone cameras using photoplethysmography for early detection of atrial fibrillation, based on the analysis of beat-by-beat duration variability series, has initially proved its value in a prospective two-center, international clinical validation study [40], the validation of using smartphone accelerometers is still limited and again focusing on beat-by-beat duration variability only [16], [17], [41], [42].…”
Section: Discussionmentioning
confidence: 99%
“…We included 10 primary diagnostic accuracy studies 15,16,[27][28][29][30][31][32][33][34] 27 which was excluded from the primary analysis, as described in the Methods section. The applications analyzed the pulsewave signal for a mean (range) of 2 (1)(2)(3)(4)(5) minutes.…”
Section: Study Selection and Characteristicsmentioning
confidence: 99%
“…We conducted a number of sensitivity analyses that explored the associations of methodological variation with our results, including investigating the associations of verification bias, which occurred in 2 studies. 30,31 Two studies 15,34 excluded results based on PPG signal quality (7.3% for 1 study 15 Preventicus with 95% CI Cardiio Rhythm with 95% CI FibriCheck with 95% CI PULSE-SMART with 95% CI…”
Section: Quality Assessmentmentioning
confidence: 99%
See 1 more Smart Citation
“…The direct to consumer or wearable technology market, comprised of devices that monitor physiological parameters such as heart rate and sleep pattern, is anticipated to grow to 929 million connected devices by 2021 87 . These devices encompass wristbands, glasses, in‐ear monitors, chest straps, and smart phone‐enabled recording electrode systems or electronic shirts, with varying capacity to monitor heart rate, heart rhythm, blood pressure, physical activity, respiratory rate, blood glucose, and sleep patterns 88–90 . For heart rate monitoring, most wearable devices use photoplethysmography (PPG) technology, meaning they are inherently less accurate than conventional electrocardiography monitoring techniques.…”
Section: General Tools For Risk Assessment Strengths Limitations Amentioning
confidence: 99%